The pathophysiology of thyroid-associated ophthalmopathy

Ophthalmology Clinics of North America

Volumn 15, Issue 1, 2002, Pages 113-119

  Hatton, Mark P ^a   Rubin, Peter A D ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; PROTIRELIN RECEPTOR;

CELL PROLIFERATION; CLINICAL FEATURE; ELECTROMYOGRAPHY; EXTRACELLULAR MATRIX; EXTRAOCULAR MUSCLE; EYE DISEASE; FIBROBLAST; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY CELL; OPTIC NERVE; ORBIT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; THYROID DISEASE;

GRAVES DISEASE; HUMANS;

EID: 0036014913     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(01)00004-9     Document Type: Article

References (77)

1. Relationship between disease duration and predominant orbital T cell subset in Graves' ophthalmopathy
2. T cell responses to orbital antigens in thyroid-associated ophthalmopathy
3. The fibroblast is the target cell in the connective tissue manifestations of Graves' disease
4. Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin
5. Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: Potential autoantigen in Graves' ophthalmopathy
6. Identification of autoantigen recognized by autoimmune ophthalmopathy sera with immunoblotting correlated with orbital computerized tomography
7. Localization of the human 64kD autoantigen D1 to myofibrils in a subset of extraocular muscle fibers
8. Thyrotropin receptor transcripts in human adult adipose tissue
9. Adipogenesis in thyroid eye disease
10. Thyrotropin receptors in adipose tissue, retroorbital tissue and lymphocytes
11. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves' disease patients followed up for development of ophthalmopathy
12. Cytolytic T cells with Th1-like cytokine profile predominate in retroorbital lymphocytic infiltrates of Graves' ophthalmopathy
13. Cloning and sequencing of a novel 64-kDa autoantigen recognized by patients with autoimmune thyroid disease
14. Muscle auto-antigens in thyroid associated ophthalmopathy: The limits of molecular genetics
15. Expression of thyrotropin receptor mRNA in healthy and Graves' disease retroorbital tissue
16. Analysis of orbital T cells in thyroid-associated ophthalmopathy
17. Retrobulbar T cells from patients with Graves' ophthalmopathy are CD8+ and specifically recognize autologous fibroblasts
18. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism
19. Cloning and characterization of the novel thyroid and eye muscle shared proteins G2s: Autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism
20. Role of the eye muscles in thyroid disease: Identification of the principal autoantigens
21. Increased sulfation of orbital glycosaminoglycans in Graves' ophthalmopathy
22. Effects of thyrotropin on the proliferation and differentiation of cultured rat preadipocytes
23. Involvement of the orbital fibroblast and TSH receptor in the pathogenesis of Graves' ophthalmopathy
24. Graves' immunoglobulins and cytokines stimulate the expression of intercellular adhesion molecule-1 (ICAM-1) in cultured Graves' orbital fibroblasts
25. Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy
26. Elevated expression in situ of selectin and imunoglobulin superfamily type adhesion molecules in retroocular connective tissues from patients with Graves' ophthalmopathy
27. Modulation of Graves' orbital fibroblast proliferation by cytokines and glucocorticoid receptor agonists
28. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy
29. Characterization of adhesion receptors on cultured miscrovascular endothelial cells derived from the retroorbital connective tissue of patients with Graves' ophthalmopathy
30. Increased induction of HLA-DR by interferon gamma in cultured fibroblasts derived from patients with Graves' ophthalmopathy and pretibial dermopathy
31. Cell surface localization of a 72 kilodalton heat shock protein in retroocular fibroblasts from patients with Graves' ophthalmopathy
32. Significance of cytotoxic eye muscle antibodies in patients with thyroid-associated ophthalmopathy
33. A thyroid cytotoxic antibody that cross-reacts with an eye muscle cell surface antigen may be the cause of thyroid associated ophthalmopathy
34. Immunohistochemical and ultrastructural studies on the exenterated orbital tissues of a patient with Graves' disease
35. Endocrine ophthalmoplegia: Is it due to myopathy or mechanical immobilization?
36. Expression of hyaluronan synthase messenger ribonucleic acids and their induction by interleukin-1 beta in human orbital fibroblasts: Potential insight into the molecular pathogenesis of thyroid associated ophthalmopathy
37. Immunohistochemical staining of retrobulbar adipose tissue in Graves' ophthalmopathy
38. A 64 kDa membrane antigen is a recurrent epitope for natural autoantibodies in patients with Graves' thyroid and ophthalmic diseases
39. Failure to demonstrate cell-mediated immunity to orbital tissue antigens and epitopic fragments of a 64 kDa protein in the majority of patients with thyroid-associated ophthalmopathy
40. Demonstration of a circulating autoantibody against a soluble eye-muscle antigen in Graves' ophthalmopathy
41. Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy
42. Serological reactivity of recombinant 1D autoantigen and its expression in human thyroid and eye muscle tissue: A possible autoantigenic link in Graves' patients
43. The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: The corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidism
44. Reevaluation of the prevalences of serum autoantibodies reactive with "64-kDa eye muscle proteins" in patients with thyroid-associated ophthalmopathy
45. Development of an animal model of autoimmune thyroid eye disease
46. Studies on the occurrence of ophthalmopathy in Graves' disease
47. Endocrine ophthalmopathy: A re-evaluation of the association with thyroid autoantibodies
48. Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue
49. Stimulation of extraocular muscle fibroblasts by cytokines and hypoxia: Possible role in thyroid-associated ophthalmopathy
50. Significance of antibodies reactive with a 64 kDa eye muscle membrane antigen in patients with thyroid autoimmunity
51. Orbital tissue-derived T-lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens
52. Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO)
53. Adhesion molecule expression in vivo on extraocular muscles (EOM) in thytoid-associated ophthalmopathy
54. Demonstration of thyrotropin binding sites in orbital connective tissue: Possible role in the pathogenesis of thyroid-associated ophthalmopathy
55. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease
56. Prevalence of antibodies reactive with a 64 kDa eye muscle membrane antigen in thyroid-associated ophthalmopathy
57. Human orbital tissue and thyroid membranes express a 64 kDa protein which is recognized by autoantibodies in the serum of patients with thyroid-associated ophthalmopathy
58. Patients with endocrine ophthalmopathy not associated with overt thyroid disease have multiple thyroid immunologic abnormalities
59. Endocrine ophthalmoplegia: With an electromyographic study of paretic extraocular muscles
60. Stimulation of glucose utilization and glycosaminoglycan production by fibroblasts derived from retrobulbar tissue
61. Enlargement of levator palpebrae superioris muscle fibers in Graves' ophthalmopathy
62. Hormonal regulation of hyaluronate synthesis in cultured human fibroblasts: Evidence for differences between retroocular and dermal fibroblasts
63. Stimulation of glycosaminoglycan accumulation by interferon gamma in cultures human retroocular fibroblasts
64. Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture
65. Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue
66. Cellular immunity and retrobulbar fibroblasts in Graves' ophthalmopathy
67. Immunohistochemical staining of normal and Graves' extraocular muscle
68. Correlation of CT scanning and pathologic features of ophthalmic Graves' disease
69. Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor
70. Both Th1-and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy
71. Immunohistochemical analysis of retrobulbar tissues in Graves' ophthalmopathy
72. B cell reactivity to extraocular and skeletal muscle in Graves' ophthalmopathy
73. Ultrasonographic evidence of a consistent orbital involvement in Graves' disease
74. Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease
75. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization
76. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and non-thyroid diseases
77. Tissue distribution and quantification of a gene expressing a 64-kDa antien associated with thyroid-associated ophthalmopathy